The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $27.05

Today's change-0.37 -1.35%
Updated July 27 4:01 PM EDT. Delayed by at least 15 minutes.
 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $27.05

Today's change-0.37 -1.35%
Updated July 27 4:01 PM EDT. Delayed by at least 15 minutes.

Boston Scientific Corp down (U.S.)$0.37

Boston Scientific Corp closed lower Thursday, dropping (U.S.)$0.37 or 1.35% to (U.S.)$27.05. Shares have lost 2.45% over the last five days, but have gained 25.06% over the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $27.24
  • Previous close(U.S.) $27.42
  • High(U.S.) $27.51
  • Low(U.S.) $26.68
  • Bid / Ask-- / --
  • YTD % change+25.06%
  • Volume13,914,634
  • Average volume (10-day)5,200,063
  • Average volume (1-month)6,418,944
  • Average volume (3-month)6,592,835
  • 52-week range(U.S.) $19.67 to (U.S.) $28.51
  • Beta1.10
  • Trailing P/E86.35×
  • P/E 1 year forward21.94×
  • Forward PEG2.04×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.31
Updated July 27 4:01 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.13%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue2,1602,1912,1052,126
Total other revenue--------
Total revenue2,1602,1912,1052,126
Gross profit1,5221,5861,5191,494
Total cost of revenue638605586632
Total operating expense1,7962,0511,7572,460
Selling / general / administrative791828768774
Research & development235256232222
Depreciation / amortization143137136135
Interest expense (income), net operating--------
Unusual expense (income)-2820515677
Other operating expenses, total17202020
Operating income364140348-334
Interest income (expense), net non-operating-57-58-58-59
Gain (loss) on sale of assets--------
Other--------
Income before tax30589257-397
Income after tax290124228-207
Income tax, total15-3529-190
Net income290124228-207
Total adjustments to net income--------
Net income before extra. items290124228-207
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items290124228-207
Inc. avail. to common incl. extra. items290124228-207
Diluted net income290124228-207
Dilution adjustment--------
Diluted weighted average shares1,3901,3841,3611,357
Diluted EPS excluding extraordinary itemsvalue per share0.210.090.17-0.15
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.190.190.180.17